Endogenous Metabolite (EM) Information
Endogenous Metabolite (EM) Information | ||||||
---|---|---|---|---|---|---|
EM ID |
EM00160
|
|||||
EM Name |
Leukotriene C4
|
|||||
Synonyms |
leukotriene C4; LTC4; Leukotriene C; LTC (sub 4); 5S,6R-Ltc(sub 4); UNII-2CU6TT9V48; 2CU6TT9V48; CHEBI:16978; GWNVDXQDILPJIG-NXOLIXFESA-N; Leukotriene C(sub 1); Leukotriene C(sub 4); 5S-hydroxy,6R-(S-glutathionyl),7E,9E,11Z,14Z-eicosatetraenoic acid; C30H47N3O9S; LTX; (5S,6R,7E,9E,11Z,14Z)-6-[(2R)-2-[[(4S)-4-amino-5-hydroxy-5-oxopentanoyl]amino]-3-(carboxymethylamino)-3-oxopropyl]sulfanyl-5-hydroxyicosa-7,9,11,14-tetraenoic acid
|
|||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=5280493"></iframe>
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C30H47N3O9S
|
|||||
Canonical SMILES |
CCCCCC=CCC=CC=CC=CC(C(CCCC(=O)O)O)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N
|
|||||
InChI |
InChI=1S/C30H47N3O9S/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-25(24(34)15-14-17-27(36)37)43-21-23(29(40)32-20-28(38)39)33-26(35)19-18-22(31)30(41)42/h6-7,9-13,16,22-25,34H,2-5,8,14-15,17-21,31H2,1H3,(H,32,40)(H,33,35)(H,36,37)(H,38,39)(H,41,42)/b7-6-,10-9-,12-11+,16-13+/t22-,23-,24-,25+/m0/s1
|
|||||
InChIKey |
GWNVDXQDILPJIG-NXOLIXFESA-N
|
|||||
CAS Number |
CAS 72025-60-6
|
|||||
Pharmaceutical Properties | Molecular Weight | 625.8 | Topological Polar Surface Area | 242 | ||
Heavy Atom Count | 43 | Rotatable Bond Count | 25 | |||
Hydrogen Bond Donor Count | 7 | Hydrogen Bond Acceptor Count | 11 | |||
PubChem CID | ||||||
ChEBI ID |
CHEBI:16978
|
|||||
DT(s) "handling" This EM | MRP8 | Transporter Info | Multidrug resistance-associated protein 8 | [1] | ||
References | ||||||
1 | Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development. Curr Med Chem. 2008;15(20):1981-2039. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.